This Weekend my eyes and thoughts
curved around the Healthcare sector.
I read several interesting articles from the sector, mostly about the biotech’s and new Hepatitis C drugs from Gilead, Sovaldi and Harvoni.
I read several interesting articles from the sector, mostly about the biotech’s and new Hepatitis C drugs from Gilead, Sovaldi and Harvoni.
Those are very
expensive drugs with potential to kill the current medical systems but they also generate tons of cash for their corporate.
I also noticed
that the Healthcare sector grows at a much faster pace than the economy does,
with 10+ percent. How can you benefit from this trend? I don't know. Prices are high, even on free
cash flow basis.
Second, the old
synthetic drug cash cow system from Pfizer doesn't work anymore. PFE is losing
revenues. Even Teva, a generic drug manufacturer, struggles.
In order to get an
overview about modest valuated growth stocks from the Healthcare sector, I've
created a screen for large capitalized sector members with the following main
criteria:
- EPS growth next
five years: over 5 percent
- Sales growth
past five years: over 5 percent
- Forward P/E
under 20
- Positive
Dividend
14 attractive healthcare growth stocks remain. It's a very selective list with focus on sales and
earnings growth. You can find the full results attached.
You may also interested in my older articles about healthcare dividend stocks.
Below are also five of my favorites. Which stocks do you like? Please let me know.
You may also interested in my older articles about healthcare dividend stocks.
Below are also five of my favorites. Which stocks do you like? Please let me know.